Endo Ventures Unlimited Co. v. Nexus Pharms. Inc. – Ephedrine Sulfate

Start
Case Name: Endo Ventures Unlimited Co. v. Nexus Pharms. Inc., Civ. No. 23-cv-299-BHL, 2024 WL 1254358 (E.D. Wis. Mar. 25, 2024) (Ludwig, J.) – Drug Product and Patent(s)-in-Suit: ephedrine sulfate; U.S. Patents Nos. 10,869,845 (“the ’845 patent”) and 11,491,121 (“the ’121 patent”)….
By: Robins Kaplan LLP
Previous Story

Catholic Diocese of Cleveland Data Breach Leaks an Unknown Number of SSNs and Other Confidential Information

Next Story

Emerging Trends in Second Requests